İbrahim Halil Şahin

Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations

Zishuo I. Hu, Jinru Shia, Zsofia K. Stadler et al. · Clinical Cancer Research · 2018 · 363 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer

İbrahim Tekedereli, S. Neslihan Alpay, Clint D.J. Tavares et al. · PLoS ONE · 2012 · 118 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Prognostic Indicators and Treatment Outcome in 94 Cases of Fibrolamellar Hepatocellular Carcinoma

Ahmed O. Kaseb, Mohamed Shama, İbrahim Halil Şahin et al. · Oncology · 2013 · 97 citations · Full text

Medicine, Oncology, Surgery +16

A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer

Richard D. Kim, Bence Kővári, María Carmen Riesco Martínez et al. · European Journal of Cancer · 2022 · 89 citations

Medicine, Oncology, Molecular Oncology +11

Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior

İbrahim Halil Şahin, Harold K. Elias, Joanne F. Chou et al. · BMC Cancer · 2018 · 66 citations · Full text

Medicine, Oncology, Surgery +17